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THERE is now a considerable amount of evidence available to show that
breast carcinogenesis by methylcholanthrene (MC) in agent-free mice is aug-
mented in cases where high levels of progesterone are believed to be operating.
V'irgin female mice of the BALB/c, DBA, L(P) and C57B1 strains are all resistant
to breast tumour induction by MC, but are susceptible if maintained in a state of
pseudopregniancy by caging them in the presence of vasectomised males,
(Biancifiori, Bonser and Caschera, 1959; Ranadive, Hakim and Kharkar, 1960;
Marchant, 1961a). The susceptibility of breast tissue of virgin mice of strains
such as the IF to tumour induction by MC may be attributed to the high incidence
of sponitaneous pseudopregnancy occurring when these animals are caged in
groups (Muhlbock and Boot, 1960). Their susceptibility may be further increased
if the animals are caged with vasectomised males (Marchant, 1958).
Jull (1956) compared the mechanism of action of carcinogenic chemicals onl
mouse breast tissue with the action of chemical carcinogens on the skin, demon-
strated bv Berenblum and Shubik (1947). The latter authors showed that the
chemical carcinogen could initiate skin tumours with only a single application.
provided this was followed by repeated application of a " co-carcinogen " to
promote the development of tumours. In the case of the breast, Jull suggested
that the carcinogens mimic the physiological action of some steroid hormone, but
that their different structure produces an abnormality in the hormonal mechanism
so that further excitation of that mechanism causes an abnormal course of events
to ensue, resulting in some cases in malignant growth. He presented evidence that
the carcinogens methylcholanthrene (MC) and dimethylbenzanthracene (DMBA)
had progesterone-like effects, while dibenzanthracene (DBA) and benzopyrene
(BP) had oestrogen-like effects. He suggested that the chemicals acted as initiat-
ing agents in breast carcinogenesis and the hormones which they mimic act as
promoting agents.
The evidence already discussed would support Jull's general hypothesis as far
as AC is concerned, but there is little information available about the action of
other breast carcinogens. It is known that DMBA induces a high incidence of
breast tumours in virgin mice of the IF strain (Howell, Marchant and Orr, 1954),
which has a high incidence of spontaneous pseudopregnancy, and a low incidence
in the C57B1 and A strains (Marchant, 1957), which has a low incidence of spon-
taneous pseudopregnancy. Thus, like MC, the progesterone-mimetic DMBA is
capable ofinducing breast tumours when high levels ofprogesterone are operating.JUNE MARCHANT
Breast tumour induction with DBA and BP has been studied even less. Bonser
(1958) compared the action of the four chemicals on the breast tissue of virgin IF
mice. She obtained a high incidence of tumours with DBA, but they were much
later than those obtained after DMBA or MC. With BP, only a small number of
late tumours arose. When these 4 carcinogens were tested on agent-free C3Hb
virgins, which have a low incidence of spontaneous pseudopregnancy, the greatest
incidence oftumours was obtained after MC; DMBA produced fewer tumours but
they occurred much earlier than with MC; DBA was only slightly effective and
BP ineffective in inducing breast tumours, (Biancifiori, Bonser and Caschera,
1961).
In the present communication, the action of these 4 carcinogens is compared
on virgin and pseudopregnant C57B1 mice. It is known that virgin animals of
this strain are resistant to breast tumour induction by MC, but that they are
sensitive if maintained with vasectomised males (Marchant, 1961a). As a
further extension of this experiment, it was thought of interest to see what would
happen if virgin mice were treated with MC and then maintained with vasecto-
mised males, as this would be more comparable with Berenblum and Shubik's
(1947) experiments, exposing the tissue first to the action of the chemical and
subsequently to the action of the
" promoting" stimulus in this case the hor-
monal conditions of pseudopregnancy.
MATERIALS AND METHODS
Mice.-Adult female C57B1 mice were used in this study. They were housed
in metal boxes measuring 20 x 28 x 11 cm. and were fed a cube diet with water
ad libitum. Six virgin female mice were kept per cage. Four pseudopregnant
females were kept with 2 vasectomised males. The time between the mating of
the mice and the first carcinogen application varied. In the case of BP it was
4 months, MC 2 months, DBA 3 weeks and DMBA 1 week.
Carcinogen treatment.-0 5 per cent solutions in olive oil were made of each of
the four carcinogens, DMBA, MC, DBA, and BP. In the case of DBA the solu-
tion was saturated at this strength, and it was shaken up before application.
Approximately 0 5 ml. (2.5 mg.) of one of these oily solutions was applied to the
skin of each female mouse at fortnightly intervals. The number of paintings
received by each group is shown in Table I.
Mice were kept as long as their condition remained good. They were examined
regularly for the development of tumours and breast tumour material was fixed
post mortem in formol saline and sectioned for histological examination. Whole-
mount preparations were made from samples of breast tissue from each of the
experimental groups. Ovaries were also examined and many of them were
sectioned.
RESULTS
Survival.-The survival of the mice in the various groups was largely de-
pendent on whether, or not, tumours of the breast or skin appeared. The longest
survival time was 120 weeks from the first carcinogen painting and many of the
mice survived at least one year.
Tumour induction.-The incidence of breast, skin and ovarian tumours in-
duced by the 4 carcinogens is given in Table I. The results from 2 previous
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TABLE I. Incidence of Turnours Induced by FourChemnical(Carcinogens in Virgin
and PseudopregnantC57Bl Mice
Fort-
nightly
paint- Numn- Breast tumours Skin tuiniours Ovarian tuinouius
ings ber, -
Carcino- of Status of of Num- Per Nurn- Per Num- Per Mean survival
gen 2-5 mg. mice Mlice ber cent ber cent ber cent Weeks (range)
BP 8 times Virgin 16 0 0 8 50 0 0 90 (59-105)
BP 8 times Pseudopregnant 18 0 0 6 33 0 0 81 (29-120)
DBA 8timnes Virgin 17 4 24 7 41 1 6 86 (54-103)
DBA 8 times Pseudopregnant 14 2 14 2 14 0 0 81 (45-99)
DMBA 6 times Virgin 14 1 7 6 43 1 7 48 (28-63)
*DMBA For life Virgin 27 0 0 13/16 81 3 11 40 (22-54)
DMBA 6 tirnes Pseudopregnant 29 21 72 5 17 4 14 29 (12-64)
tMC For life Virgin 14 2 14 11 79 0 0 37 (19-41)
tMC 8 tirnes Pseudopregnant 21 ll 52 6 29 0 0 46 (24-83)
MC 8 times Virgin during 18 3 17 10 56 0 0 57 (30 95)
treatment, then
pseudopregnant
* From Marchant (1957)
t From Marchant (1961 a)
experiments are included for comparison. Lvmphomatosis was also found in a
small number of mice.
Breast tumours
The distribution of breast tumours is shown in Fig. 1. No breast tumours
appeared in mice treated with BP, although the mean survival of these mice was
longer than after any of the other carcinogens. After DBA, the incidence in
virgins and pseudopregnant mice was low and the latent period long. Virgin
mice treated with MC or DMBA had very few tumours, but pseudopregnant mice
treated with these carcinogens had a high incidence of tumours in the earlv part
of the experiment, particularly after DMBA treatment.
Fig. 2 and 3 show the mortality rates from breast tumours, corrected for deaths
due to other causes by the method of Pilgrim and Dowd (1963). A straight line
indicates a constant mortality rate. The virgin mice are illustrated by Fig. 2.
It will be seen that the lines are roughly parallel for MC, DMBA and DBA, but
the slopes were very gradual. This indicates similar, but very slow, rates of
tumour development after these carcinogens. The onset of tumours was earliest
in the group treated with MC whose treatment was not limited, as in the other
cases. Mice, treated with MC while kept in the virgin state and then mated to
vasectomised males, seemed to behave like the virgins treated with the same
chemical.
Fig. 3 shows that in the pseudopregnant mice the rates of breast tumour
mortality were much greater than in the virgins, indicated by the steeper slopes
of the lines. Again they were roughly parallel for MC, DMBA and DBA, indicat-
ing similar rates of appearance, but the latent periods were very different. The
onset of tumours occurred at about 8 weeks after DMBA, 20 weeks after MC and
64 weeks after DBA. In less than the mean survival time of the groups treated
withMC and IDBA, a level was reached after which no further mortality from breast
tumours occurred. In the case of DMBA, a similar level seemed to be reached,
I2IJUNE MARCHANT
o Mourn dyingwithout breastorawarian tumours
0 Mau" dying with bram tumour
1 Mouse dying withovian tumeur
* Moasu dying with breatndaovarian tumours
rl n . Hrl -dlm ri-I
BP pseudPonnt
_ n e"R ~~~~~~~~~~~~~~~~~~~~~~~1.20.
DBA virgins I a
DbA peudapregnant
MC virn
MC pseudopregnont
MC as virgin. thin mad psuaprnt
DMBA virgins
Thmnr r DMBA pseudaprewnan
Ft2 24 36 96 we ----}. - 1 ~ ~ 36 48 60 72' 84 9 O
Weks fefirs crcigoo tnwment
FIG. 1.-Distribution of breast and ovarian tumours in C57B1
female mice after treatment with chemical carcinogens.
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FIG. 2.-Breast tumour mortality rates of virgin female C57B1
after treatment with various chemical carcinogens.
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until the last remaining survivor developed a breast tumour. This mouse was
also found to have a huge granulosa-celled tumour in one ovary.
Morphologically, the tumours showed the well-known variety of structure and
there seemed to be no correlation of tumour type with the particular carcinogen
used. However, in the pseudopregnant group treated with DMBA there was a
certain correlation of tumour type with the time of appearance of the tumour.
The earliest tumours were markedly squamous, but after 16 weeks, or so, the more
glandular types oftumour appeared and sometimes they had a very little secretion
WEEKS FROM FIRST CARCINOGEN TREATMENT
Fi(;. 3. Breast tumour rnortality rates of pseudopregnant C.57B1
rnice after treatment with various chemnical carciinogenis.
in the tubules. Squamous metaplasia was more rare and frequently absent from
the later tumours, some of which were of the papillarv cvstic type.
Whole-mount preparations ofnon-tumourous breast tissue showed considerable
varietv. The breast tissue of normal virgin C57B1 mice consists of a branch-
ing duct system devoid of acini, while that of pseudopregnant mice shows a slight
regular development of fine duct branches and terminal acini. In virgin and
pseudopregnant mice treated with carcinogens, swollen ducts were sometimes
seen, particularly in the groups treated with DMBA. Acini were seen in a few
animals, most consistently in mice of the pseudopregnant group treated with BP
which died before 18 months. Pseudopregnant mice treated with DMBA had
good acinar development in only 4 cases, the 2 mice dying earliest in the group and
2 mice dving later which were found to have ovarian tumours. Most of the
mice in this high tumour group had breast tissue devoid of acini at the time of
death.
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Nodules of hyperplasia were found in some mice in all groups. In no group
were they frequent, but they were found more often in the groups with the highest
breast tumour incidences and were very rarely seen in mice treated with BP.
Ovarian tumours
Unilateral macroscopic granulosa-celled tumours of the pseudofollicular type
were found in the ovaries of 4 ofthe 29 pseudopregnant mice treated with DMBA.
They appeared after 28 weeks. Bilateral tumours were found in the 1 virgin
mouse out of 14 treated with DMBA which developed a breast tumour. One tiny
nodule of granulosa-celled tumourwas found in a mouse treated with DBA, but 3
others had a large blood clot in one ovary after this carcinogen. A few also had
small cysts filled with clear fluid, and some of the longest survivors had tubular
proliferation in their ovaries. After BP treatment, 2 large blood clots were found
and 3 mice had clear cysts. In MC treated mice a small number of tiny cysts or
haemorrhagic follicles were found. No tumours or tubular proliferation were
seen after BP or MC. Follicles with oocytes were seen in very few of the ovaries
examined and these were in the mice dying early for their group.
Skin tumours
Skin tumours occurred in many mice of all groups, the incidence beinig lower
in the present experiments, where carcinogen treatment was limited, than in the
previous experiments, where it was given throughout life. The incidence of skin
tumours invirgin mice was consistently higherthan inpseudopregnant micetreated
with the same carcinogen. This may be partly accounted for by the longer
survival of the virgin mice allowing a longer period of time for the tumours to
develop.
DISCUSSION
The above results indicate that, with the progesterone-mimetic chemicals
DMBA and MC, there was a dramatic increase, associated with the hormonal
conditions of pseudopregnancy, in the incidence of breast tumours and the rate of
their appearance in C57B1 mice. With the oestrogen-mimetic chemicals DBA and
BP the tumour appearance was not changed by pseudopregnancy. These facts
would fit in with Jull's (1956) general hypothesis that the 2 groups of carcinogens
work by different mechanisms, carcinogenesis by MC and DMBA being favoured
by conditions of high progesterone activity.
Some experiments have indicated that MC is able to induce breast tumours in
tissue which is exposed to certain growth-promoting hormonal stimulation at
the time ofaction ofthe carcinogen, but, ifthe carcinogen treatment is given before
the action of the same hormonal stimulus, tumours do not appear (Haran-Ghera,
1961; Marchant, 1961b). It would seem that appropriate hormonal stimulation
is required, to provide tissue in a condition susceptible to the action of the
carcinogen, as well as to develop tumours from tissue which has been acted upon
by the carcinogen. Both these aspects of hormonal stimulation may be of im-
portance in considering the reasons for failure of breast tumours to appear in mice
after MC treatment which is adequate to produce them in other mice.
The failureof breast tumours toappear in substantial numbersofvirgin female
C57B1 mice after MC or DMBA treatment may be accounted for by the low
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incidence of spontaneous pseudopregnancy in these mice. Few of them would
have the high progesterone levels which seem to be required. The tumour inci-
dence in MC-treated virgins could not be increased in the present experiments bv
subsequently mating them with vasectomised males, in order to expose them to
the high progesterone levels of pseudopregnancy. It would seem that, in the case
of C57B1 virgins, the low progesterone levels of the majority mav possibly be
having their inhibitory effect on tumour production by preventing the tissuie from
being susceptible to the action of MC. On the other hand, if high progesterone
levels are required for their development phase, the failure of the tumour level
to be increased by subsequent mating of the treated virgins with vasectomised
males might have another explanation. It could be that the ovaries of these
mice had been affected by the MC treatment and were no longer able to respond
by producing high progesterone levels normally associated with pseudopregnancy.
Further wrork would be required to distinguish between these possibilities.
The failure of breast tumours to appear in the last survivors of several groups
of mice, (for instance, those shown in Fig. 3) is probably associated with waning
of the ovarian secretioni required for the development of tumours from breast
tissue which has been changed by the action ofthe carcinogen. Such waning may
be due to the age of the mice, or to the effect of the carcinogen treatment on their
ovaries. Of the 4 carcinogens used, DMBA is known to have by far the greatest
effect upon mouse ovaries (Mody 1960 Biancifiori et al. 1961). It rapidly
causes the destruction of oocytes and this is followed by the disappearance of
the corpora lutea (Marchant, 1959). A diminution ofovarian secretion goes hand-
in-hand with these changes, unless a granulosa-celled tumour secreting hormones
developes. In this connection, it is of interest that the unexpected appearance of
a breast tumour in the last survivor of the pseudopregnant group ofC57B1 treated
with DAIBA was associated with a large ovarian tumour, which may have been
the source of the hormonal stimulation required for its development.
The C3Hb virgin female mice used by Biancifiori et al. (1961) might have been
expected, on Jull's (1956) hypothesis, to be rather insensitive to breast tumour
iniduction bv DMBA and MC, since they have a rather low incidence ofspontaneous
pseudopregnancy. They were, however, found to be fairly sensitive to these
carcinogens, both of which produced a good yield of granulosa-celled tumours
of the ovaries, at about the same time as the development of the mammarv
tumours. Nearly all the tumours ofboth kinds occurred between 10 and 40 weeks
after DMBA treatment, and between 40 and 70 weeks after MC treatment. DBA
and BP produced almost no tumours of either kind. The unexpected sensitivitv
of the C3Hb mice to breast tumour induction by IDMBA and MC may, therefore,
be largely due to their sensitivity to the induction of hormone-producing ovarian
tumours by these carciniogens, rather than to their rather limited tendenev to
undergo spontaneous pseudopreginancy.
StUMMARY
'Breast tumour iniduction by 4 carcinogens has been compared in virgiin and
pseudopregnant female mice of the ('57B1 strain. In virgin mice their potency
as breast carcinogens was low, but in pseudopregnant mice the potency of DMBA
was greatly increased and that of MC to a less extent, while the potencies of BP
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and DBA were not affected. Virgin mice treated with MC and subsequently made
pseudopregnant did not show an increased tumour incidence.
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